Immunity at Body Surfaces



Immunity at Body Surfaces



Although mammals possess an extensive array of innate and adaptive defense mechanisms within tissues, it is at their surfaces that invading microorganisms are first encountered and largely repelled or destroyed (Figure 22-1). Although the skin is the most obvious of these surfaces, it in fact represents only a small fraction of the area of the body exposed to the exterior. The areas of the mucous membranes of the intestine and respiratory tracts are at least 200 times larger. While the immune systems ensure that the interior of the body remains free of microbial invaders, it is not possible to keep the surfaces of the body sterile. Indeed a vast number of microorganisms live in a symbiotic relationship on body surfaces. These organisms are not a major threat to healthy individuals. Many are commensals whose presence is beneficial. This complex microflora is present in large numbers on all the body’s surfaces, including the skin, gastrointestinal tract, respiratory tract, and urogenital tract.




The Body’s Microflora


The immune system functions on the basis that microorganisms that invade the body must be eliminated. Organisms that penetrate the epithelial barriers are promptly detected, attacked, and destroyed by innate and adaptive mechanisms. The situation is different outside the body. Almost every surface is teeming with a large stable population of microorganisms collectively called the microflora or microbiota. This is an example of symbiosis—the living together in close union of very dissimilar organisms. Animal surfaces are a stable, nutrient-rich ecosystem where microbes can thrive. Because animals also benefit from the presence of these symbiotic microbes, as, for example, in the bovine rumen, these organisms can be considered commensals.



The Superorganism


Of the microbes that live on the skin and mucosal surfaces, the largest such community is found in the intestine. The intestinal microflora consists of more than 1000 bacterial species in humans, with each individual housing about 160 species and about a hundred trillion (1014) bacterial cells. (Thus nine out of ten cells in the human body are bacterial. The figure for domestic mammals is unlikely to be very different!) Given the large number of bacterial species involved, they contain about 100 times more genes than the human genome. Because of the enormous number of microorganisms involved, the concept has emerged that animals together with their microflora form “superorganisms” in which enormous numbers of genes act together to promote survival and the whole is regulated by the immune system. In addition to considering the bacteria as part of the animal microbiome, it is also apparent that many viruses live within the body, collectively constituting a virome of unknown significance.


The presence of large stable populations of symbiotic bacteria implies that their elimination is neither feasible nor desirable. The immune system must therefore adapt to the presence of this microflora while at the same time retaining its ability to fight pathogens. The first bacteria to colonize body surfaces are acquired by a newborn animal from its mother at the time of birth. Within days, these are followed by many different environmentally acquired bacteria, generally as a result of chance microbial encounters. These organisms compete and adapt to their environment so that over the first months of life, their composition gradually changes to the stable adult-like microflora. The size and complexity of this microflora is greatest in the gastrointestinal tract. Most intestinal microbes are bacteria (Gram-positive and Gram-negative, facultative aerobic and anaerobic), but there are some archaea, a few eukaryotes, and many viruses and bacteriophages. The composition of the microflora varies among surfaces and even among locations on those surfaces. Additionally, the composition of the intestinal microflora differs among individuals and depends on their diet. The bacterial density is relatively low in the stomach but rises in the rumen, the distal small intestine, and especially the colon (Figure 22-2). The rumen mainly contains anaerobic bacteria, with some protozoa and fungi. In the large intestine, the microflora mainly consists of strict anaerobes. It has been estimated that this microbial population can eventually reach a density of 1012 organisms per gram of intestinal contents.



As commensals, the intestinal microflora helps to break down plant cell walls and digest complex carbohydrates such as cellulose and other plant polysaccharides. These commensals synthesize some essential vitamins and, by maintaining an appropriate balance within the microbial population, restrict the growth of potential pathogens. In addition, they play a central role in the development and regulation of the immune system.


Although essential for the health and proper functioning of the animal body, it must not be assumed that the normal microflora does not present a threat to an animal. Microbes can only be excluded by continual vigilance. Many members of the microflora can be considered pathobionts, which retain the potential to cause disease. Remember too that the decomposition of a dead animal is initiated by its own microflora around the time of death immediately after the failure of its immune defenses.



Controlling the Microflora


Animals and their microflora have coevolved as a result of the benefits gained by each partner, but the huge mass of commensal bacteria within the intestine is a potential threat to host integrity and must be closely watched by the immune system. There are two obvious threats facing any animal. The first is the critical importance of ensuring that the normal microflora is kept in its place and prevented from any attempt at invasion. The second is that the microflora and the molecules it releases might trigger innate responses such as inflammation. If these organisms can invade, and especially if they cause inappropriate inflammation, bad things will happen.



Exclusion of Commensals


The first cellular barrier to microbial invasion consists of intestinal epithelial cells (enterocytes). These cells maintain barrier integrity by having tight junctions between cells and a coating of attached mucins that form a glycocalyx, and they produce multiple antimicrobial peptides. Specialized intestinal epithelial cells called Paneth cells express toll-like receptors (TLRs) (Figure 22-3). When triggered by the microflora, they secrete multiple antimicrobial peptides. These enteric defensins, known as cryptdins, accumulate within intestinal crypts and achieve very high local concentrations. They prevent commensals from entering the crypt space and so protect enterocytes from invasion. In cattle, expression of cryptdin genes occurs throughout the small intestine and colon. These cryptdins are secreted as active molecules, as opposed to the human and mouse molecules that are secreted as inactive precursors and subsequently activated by trypsin within the intestine. Parasitic or other intestinal infections may increase production of α- and β-defensins. Cryptdins serve a barrier function since they are found in highest concentrations in the fluid layer closest to the epithelium and therefore reduce microbial contact with enterocytes. The cryptdin mixture selectively kills some bacterial species and as a result regulates the precise composition of the microflora.



The gastrointestinal mucus layer is also critical to the exclusion of both commensals and pathogens. The mucus layer consists of a gel made of mucins, glycoproteins, and lipids that prevents bacteria from contacting the epithelium. This mucus acts as a lubricant, blocks chemical insults, and can capture and then expel pathogens. The mucus forms an inner and outer layer. The inner layer next to the enterocytes consists of firm mucus rich in defensins and lysozyme and contains few bacteria. The looser mucus in the intestinal lumen is composed primarily of mucins produced by intestinal goblet cells. Many bacteria are embedded in this mucus, where it prevents their washout. Its thickness and composition vary, but it tends to be thickest where the microflora is abundant.


The epithelial cell brush border is also covered by a glycocalyx—a layer of acidic polysaccharides and glycoproteins that binds to the apical surface of the cells and serves as a protective barrier while still permitting the absorption of nutrients.



Suppression of Inflammation


As pointed out, constant inflammation is undesirable and must somehow be suppressed. The huge mass of bacteria in the intestine would be expected to produce plentiful amounts of bacteria-associated molecular patterns, and these would be expected to bind pattern-recognition receptors. Intestinal epithelial cells express pattern-recognition receptors (PRRs) such as the TLRs and NLRs. These can bind microbial-associated molecular patterns and in response trigger the production of antimicrobial peptides and cytokines but not inflammation. This is because the PRRs are not expressed on the luminal side of the epithelia, where they would normally come into contact with commensals. They are located at the base of the cells and at intracellular locations. Thus they are only triggered after bacteria penetrate the epithelial barrier. By preventing microbial invasion, they also prevent the development of inflammation within the intestinal epithelium.


Some commensal bacteria actively suppress inflammation in the intestinal wall. For example, commensal bacteria such as Lactobacillus and Bacteroides species inhibit the innate signaling pathways triggered by TLRs and NLRs. A common commensal, Bacteroides thetaiotamicron inhibits NF-κB signaling by blocking the migration of one of its subunits out of the nucleus, and intestinal lactobacilli prevent degradation of the inhibitor I-κB.


Other mechanisms such as desensitization of TLRs to bacterial PAMPs and bacterial stimulation of IL-10 and IL-2 production by regulatory Treg cells also help minimize inflammation. IL-10 inhibits the TLR-MyD88 pathway, whereas IL-2 inhibits TLR-independent pathways. Mice deficient in either IL-10 or IL-2 develop severe colitis.


Despite its defenses, however, the epithelial barrier is somewhat porous to microbial products. As a result, there is a constant interplay between the intestinal microflora and the mucosal immune system. In effect, the mass of the intestinal microflora provide a constant source of microbial products that keeps both the innate and acquired immune responses in a state of constant readiness. The intestinal microflora is especially necessary for the differentiation and recruitment of T cells since it acts as a massive source of antigenic stimulation. As a result, intestinal lymphoid tissues must be relatively unresponsive to the microflora while still being responsive to potential pathogens. Under steady-state conditions, the intestinal immune system must recognize commensal bacteria but respond in a highly regulated manner somewhat short of full activation. It is likely that the development of some forms of inflammatory bowel disease in humans and other animals is due to dysfunction in these regulatory pathways.


Although most intestinal bacteria probably suppress inflammation, others may have an opposite effect. Thus some unculturable segmented filamentous bacteria (SFBs) trigger Th17 responses in mice and promote innate responses in the intestine. In the absence of these SFBs, mice mount weaker immunoglobulin A (IgA) responses and poorer intestinal T cell responses. Unlike most intestinal bacteria that are excluded by the mucus layer and have minimal contact with the enterocytes, the SFBs attach directly to the epithelium of the ileum and Peyer’s patches and can be readily sampled by dendritic cells. SFBs have been detected in humans, rodents, chickens, and fish, so they may play an important role in shaping the development of the intestinal immune system.



Benefits of the Microflora


Exclusion of Pathogens


The intestinal microflora acts competitively against potential invaders and supplements the physical defenses of this system (Figure 22-4). By occupying and exploiting the intestinal microenvironment, commensals block subsequent colonization by pathogenic bacteria. (It is, for example, possible to block Salmonella species colonization of the chicken intestine by administering an appropriate mixture of commensal bacteria to birds.) The microflora determines local environmental conditions by, for example, keeping the pH and oxygen tension low. The microflora is also influenced by the diet; as a result, the intestine of milk-fed animals is colonized largely by lactobacilli, which produce bacteriostatic lactic and butyric acids. These acids inhibit colonization by potential pathogens such as Escherichia coli, so young animals suckled naturally tend to have fewer digestive disturbances than animals weaned early in life. Genetically identical pigs housed in an outdoor environment, an indoor environment, or experimental isolators have had their intestinal flora studied. It has been found that 90% of the bacteria within the intestine of the outdoor group were Firmicutes, especially lactobacilli. In contrast, Firmicutes constituted less than 70% of the intestinal flora in the indoor group and about 50% in the isolated pigs. Pigs from cleaner environments had smaller proportions of lactobacilli. There is a strong negative correlation between the level of lactobacilli and the level of pathogens in the intestine. These differences also influence the expression of immune system genes. For example, animals raised in isolation express more genes involved in inflammatory immune responses such as type I interferons. In contrast, genes associated with T cell function are expressed more highly in the pigs housed outdoors.




Development of Lymphoid Organs


The immune system fails to develop properly in some germ-free animals. Thus pigs or mice that are microbiologically sterile have fewer and smaller Peyer’s patches, smaller mesenteric lymph nodes, and fewer cells in their lamina propria than animals with a complete microflora. The natural development of the Peyer’s patches in the pig, and the appendix in rabbits depends upon the stimulation provided by the intestinal microflora. In the absence of this microflora, their enterocytes express fewer TLRs and MHC class II molecules. Intestinal lymphocyte numbers are reduced, and they are less cytotoxic. Systemic defects are also apparent. There are fewer CD4+ T cells in the spleen, they have fewer and smaller germinal centers as a result of reduced B cell numbers, and their immunoglobulin levels are only about 2% of normal.


Although the initial development of the mucosal lymphoid organs occurs before birth, the complete maturation of the mucosal immune system and the recruitment of IgA-producing B cells and activated T cells occurs after birth in response to signals from the intestinal microflora. These signals modulate the crosstalk between enterocytes and dendritic cells. In general the intestinal microflora stimulate the production of secretory IgA and the production of all three helper T cell subsets as well as Treg cells.



Regulation of B Cell Function


Although the microflora are separated by the glycocalyx from direct contact with enterocytes, intestinal dendritic cells can extend their processes into the intestinal lumen and capture commensal bacteria. These bacteria can persist within the dendritic cells for several days while the cells carry them into the mucosa and the mesenteric lymph nodes and present them to B cells. This induces a local IgA response that also serves to block mucosal penetration by these commensals. In addition, some commensal bacteria are taken up by specialized antigen capturing M cells, penetrate the Peyer’s patches, and become resident within the tissues. Although most of these invading bacteria are killed by macrophages, some are also presented to B cells. The repertoire of these B cells is regulated by the interaction between the intestinal microflora and the intestinal-associated lymphoid tissues. The B cells produce IgA, which may modify the composition of the intestinal microflora. The commensals are prevented from breaching the mucosal barrier by the ongoing IgA response, and the mesenteric lymph nodes form an additional barrier that prevents the commensals from reaching the systemic immune system. It is likely that a similar type of local IgA response occurs against food antigens. As a result, there is more immune activity in the intestine than in all other lymphoid tissues combined. It has been estimated, for example, that more than 80% of the body’s activated B cells are found in the intestine.


Many dendritic cells in the intestinal lymphoid tissues produce retinoic acid, a metabolite of dietary vitamin A. The ability to synthesize retinoic acid is a property of many mucosal immune cells, and this appears to be a central regulator of mucosal immunity and homeostasis. Retinoic acid induces the expression of the intestinal homing receptors α4β7 and CCR9 on T cells and B cells. In association with transforming growth factor-β (TGF-β), it enhances T cell proliferation and cytotoxicity and is especially important in promoting Th2 and Treg differentiation in the intestine and in the homing of IgA+ B cells to mucosal surfaces (Chapter 38). Retinoic acid, therefore, normally suppresses Th1 and Th17 responses and favors tolerance to food antigens.



Regulation of T Cell Function


Molecules produced by commensal bacteria can influence the functions of all the major T cell subsets. For example, Treg cells producing IL-10 are present in the intestine. Several commensal bacteria such as Bacteroides fragilis and some clostridia seem especially effective in inducing these FoxP3+, IL-10-producing T cells. The bacterial molecule polysaccharide A (PSA) is key to this process. PSA suppresses proinflammatory cytokine responses in the intestine and inhibits lymphocyte infiltration. Treg populations are reduced in germ-free mice.


Th17 cell development in the intestine is also affected by the microflora (Figure 22-5). Germ-free mice are deficient in IL-17. Segmented filamentous bacteria drive T cell development and stimulate Th17 production. SFBs also promote germinal center development, IgA production, and recruitment of intraepithelial lymphocytes. Because it is believed that Th17 cells may originate from T reg precursors, it is suggested that the microflora regulates the Th17-Treg switch.




Dysbiosis and the Hygiene Hypothesis


Changes in the composition of the intestinal microflora have been implicated in the development of allergies. The hygiene hypothesis suggests that a lack of exposure to certain commensal bacteria early in life affects the development of the immune system and increases an individual’s chances of developing allergic diseases. In support of this, it has been shown that children who develop allergic disease have different intestinal microflora than children who do not. Studies on piglets exposed to differing levels of intestinal colonization have shown that the complexity of the intestinal flora influences gene expression in the immune system. Animals with a limited intestinal flora expressed more genes involved in inflammation. Conversely, piglets with a more diverse intestinal flora expressed more genes related to T cell function. Alterations in the intestinal microflora also influence the development of autoimmune diseases such as rheumatoid arthritis, some mouse models of autoimmune arthritis, ankylosing spondylitis, insulin-dependent diabetes mellitus, and experimental autoimmune encephalitis (Chapter 35).



Mucosal Lymphoid Tissues


Because of the importance of preventing invasion through the mucosa, these surfaces contain large amounts of lymphoid tissue. Mucosal lymphoid tissues fall into two groups: sites where antigens are processed and immune responses are initiated (inductive sites), and sites where antibodies and cell-mediated responses are generated (effector sites).



Inductive Sites


The mucosa-associated lymphoid tissues (MALTs) possess the three cell types required to initiate immune responses: T cells, B cells, and dendritic cells. These tissues include lymphoid tissues in the eyelids, nasal mucosa, tonsils, pharynx, tongue, and palate (collectively called Waldeyer’s ring); Peyer’s patches; solitary lymphoid nodules; the appendix in the intestine; and numerous lymphoid nodules in the lung. These lymphoid tissues are known by their acronyms. Thus GALT (gut-associated lymphoid tissue) is the collective term for all the lymphoid nodules, Peyer’s patches, and individual lymphocytes found in the intestinal walls. Similarly, BALT is the acronym used for the bronchus-associated lymphoid tissue in the lungs. These organized lymphoid tissues, unlike lymph nodes, do not react to foreign antigens delivered through afferent lymph but rather sample them directly from the surface.


The tonsils are especially important in inducing immunity on mucosal surfaces. Some organisms, however, can overcome the defenses of the tonsils and use them as a portal of entry into the body. For example, pathogens such as bovine herpesvirus-1, Mannheimia hemolytica, Streptococcus suis, and Mycobacterium tuberculosis can persist indefinitely within the tonsils.


The surface of the intestine is covered by a layer of enterocytes that form intercellular tight junctions and which thus form an effective barrier to both microbes and macromolecules (Figure 22-6). (Molecules larger than about 2 kDa are excluded.) Obviously, some aggressive invasive bacteria may damage this barrier and trigger local inflammatory and immune responses. There are two alternative routes by which organisms and macromolecules can penetrate the intact intestinal wall and be directed toward the intestinal lymphoid tissues. One route involves penetrating specialized epithelial cells (M cells) found in the epithelium directly over aggregates of lymphoid tissue or Peyer’s patches; the other involves dendritic cells that reside in the submucosa but extend their cytoplasmic processes between the enterocytes into the intestinal lumen. The tight junctions remain intact, but antigen samples can enter within the dendritic cell cytosol. This route provides a mechanism whereby noninvasive bacteria and macromolecules can be sampled and presented to nearby T cells.



Peyer’s patches are the largest of the mucosal lymphoid tissues. A newborn calf normally has about 100 Peyer’s patches, and these may cover as much as half of the ileal surface. Collectively, therefore, the intestine contains more lymphocytes than the spleen. In ruminants and pigs, there are two types of Peyer’s patch that differ in location, structure, and functions. The ileocecal Peyer’s patches of ruminants are primary lymphoid organs, whereas the jejunal Peyer’s patches are secondary lymphoid organs (Figure 12-8). In lambs, the ileocecal patches increase in size from birth to 6 months of age and then regress, leaving only a small scar. In contrast, the jejunal patches persist throughout adult life and continue to play a major role in intestinal defense. Both types of Peyer’s patch consist of masses of lymphocytes arranged in follicles and covered with an epithelium that contains M cells. M cells are specialized epithelial cells involved in antigen transportation. They have microfolds (M) rather than microvilli on their surface (Figure 22-7). The mucus layer tends to thin out over Peyer’s patches so that the M cells protrude into the lumen. M cells phagocytose the macromolecules and microbes they encounter, but rather than destroy them, they transport the antigens to their underlying lymphoid tissue. M cells may transport soluble macromolecules such as IgA, small particles, and even whole organisms. (Some pathogens, such as salmonellae, Yersinia and Listeria species, M. tuberculosis, and the reoviruses may take advantage of the M cells and use them to gain access to the body.) The proportion of M cells in the follicle-associated epithelium varies from 10% in humans and mice to 50% in rabbits and to 100% in the terminal ileum of pigs and calves.


< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 18, 2016 | Posted by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS | Comments Off on Immunity at Body Surfaces

Full access? Get Clinical Tree

Get Clinical Tree app for offline access